Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1479

1.

Obstacles and opportunities in the functional analysis of extracellular vesicle RNA - an ISEV position paper.

Mateescu B, Kowal EJ, van Balkom BW, Bartel S, Bhattacharyya SN, Buzás EI, Buck AH, de Candia P, Chow FW, Das S, Driedonks TA, Fernández-Messina L, Haderk F, Hill AF, Jones JC, Van Keuren-Jensen KR, Lai CP, Lässer C, Liegro ID, Lunavat TR, Lorenowicz MJ, Maas SL, Mäger I, Mittelbrunn M, Momma S, Mukherjee K, Nawaz M, Pegtel DM, Pfaffl MW, Schiffelers RM, Tahara H, Théry C, Tosar JP, Wauben MH, Witwer KW, Nolte-'t Hoen EN.

J Extracell Vesicles. 2017 Mar 7;6(1):1286095. doi: 10.1080/20013078.2017.1286095. eCollection 2017 Mar 7.

2.

miR-134: A Human Cancer Suppressor?

Pan JY, Zhang F, Sun CC, Li SJ, Li G, Gong FY, Bo T, He J, Hua RX, Hu WD, Yuan ZP, Wang X, He QQ, Li DJ.

Mol Ther Nucleic Acids. 2017 Mar 17;6:140-149. doi: 10.1016/j.omtn.2016.11.003. Epub 2016 Dec 10. Review.

3.

Circulating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant Mesothelioma.

Weber DG, Gawrych K, Casjens S, Brik A, Lehnert M, Taeger D, Pesch B, Kollmeier J, Bauer TT, Johnen G, Brüning T.

Dis Markers. 2017;2017:9280170. doi: 10.1155/2017/9280170. Epub 2017 Feb 21.

4.

miRNAs associated with prostate cancer risk and progression.

Luu HN, Lin HY, Sørensen KD, Ogunwobi OO, Kumar N, Chornokur G, Phelan C, Jones D, Kidd L, Batra J, Yamoah K, Berglund A, Rounbehler RJ, Yang M, Lee SH, Kang N, Kim SJ, Park JY, Di Pietro G.

BMC Urol. 2017 Mar 20;17(1):18. doi: 10.1186/s12894-017-0206-6. Review.

5.

Sets of serum exosomal microRNAs as candidate diagnostic biomarkers for Kawasaki disease.

Jia HL, Liu CW, Zhang L, Xu WJ, Gao XJ, Bai J, Xu YF, Xu MG, Zhang G.

Sci Rep. 2017 Mar 20;7:44706. doi: 10.1038/srep44706.

6.

Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients.

Halvorsen AR, Kristensen G, Embleton A, Adusei C, Barretina-Ginesta MP, Beale P, Helland Å.

Dis Markers. 2017;2017:3098542. doi: 10.1155/2017/3098542. Epub 2017 Feb 15.

7.

Colorectal adenoma and carcinoma specific miRNA profiles in biopsy and their expression in plasma specimens.

Nagy ZB, Wichmann B, Kalmár A, Galamb O, Barták BK, Spisák S, Tulassay Z, Molnár B.

Clin Epigenetics. 2017 Feb 14;9:22. doi: 10.1186/s13148-016-0305-3. eCollection 2017 Feb 14.

8.

Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy.

Cucchiara V, Yang JC, Mirone V, Gao AC, Rosenfeld MG, Evans CP.

Cancers (Basel). 2017 Jan 16;9(1). pii: E9. doi: 10.3390/cancers9010009. Review.

9.

MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.

Miyoshi J, Toden S, Yoshida K, Toiyama Y, Alberts SR, Kusunoki M, Sinicrope FA, Goel A.

Sci Rep. 2017 Mar 6;7:43393. doi: 10.1038/srep43393.

10.

Circulating microRNAs as Potential Biomarkers of Infectious Disease.

Correia CN, Nalpas NC, McLoughlin KE, Browne JA, Gordon SV, MacHugh DE, Shaughnessy RG.

Front Immunol. 2017 Feb 16;8:118. doi: 10.3389/fimmu.2017.00118. eCollection 2017 Feb 16. Review.

11.

Circulating microRNAs Correlated with Bone Loss Induced by 45 Days of Bed Rest.

Ling S, Zhong G, Sun W, Liang F, Wu F, Li H, Li Y, Zhao D, Song J, Jin X, Wu X, Song H, Li Q, Li Y, Chen S, Xiong J, Li Y.

Front Physiol. 2017 Feb 14;8:69. doi: 10.3389/fphys.2017.00069. eCollection 2017 Feb 14.

12.

The Utilization of Formalin Fixed-Paraffin-Embedded Specimens in High Throughput Genomic Studies.

Zhang P, Lehmann BD, Shyr Y, Guo Y.

Int J Genomics. 2017;2017:1926304. doi: 10.1155/2017/1926304. Epub 2017 Jan 26. Review.

13.

A Signature of Circulating microRNAs Predicts the Susceptibility of Acute Mountain Sickness.

Liu B, Huang H, Wu G, Xu G, Sun BD, Zhang EL, Chen J, Gao YQ.

Front Physiol. 2017 Feb 8;8:55. doi: 10.3389/fphys.2017.00055. eCollection 2017 Feb 8.

14.

Identification of miRNA-mRNA Modules in Colorectal Cancer Using Rough Hypercuboid Based Supervised Clustering.

Paul S, Lakatos P, Hartmann A, Schneider-Stock R, Vera J.

Sci Rep. 2017 Feb 21;7:42809. doi: 10.1038/srep42809.

15.

Integration of microRNA and mRNA expression profiles in the skin of systemic sclerosis patients.

Zhou B, Zuo XX, Li YS, Gao SM, Dai XD, Zhu HL, Luo H.

Sci Rep. 2017 Feb 17;7:42899. doi: 10.1038/srep42899.

16.

miRNA-21 as a novel therapeutic target in lung cancer.

Markou A, Zavridou M, Lianidou ES.

Lung Cancer (Auckl). 2016 Mar 2;7:19-27. doi: 10.2147/LCTT.S60341. eCollection 2016 Mar 2. Review.

17.

Update on biomarkers for the detection of lung cancer.

Jantus-Lewintre E, Usó M, Sanmartín E, Camps C.

Lung Cancer (Auckl). 2012 Jun 11;3:21-29. doi: 10.2147/LCTT.S23424. eCollection 2012 Jun 11. Review.

18.

Circulating micro-RNAs as biomarkers of coronary artery disease: is it ready for primetime or still a work in progress?

Hazarika S, Annex BH.

Ann Transl Med. 2017 Jan;5(1):10. doi: 10.21037/atm.2017.01.05. No abstract available.

19.

Stability of Circulating Blood-Based MicroRNAs - Pre-Analytic Methodological Considerations.

Glinge C, Clauss S, Boddum K, Jabbari R, Jabbari J, Risgaard B, Tomsits P, Hildebrand B, Kääb S, Wakili R, Jespersen T, Tfelt-Hansen J.

PLoS One. 2017 Feb 2;12(2):e0167969. doi: 10.1371/journal.pone.0167969. eCollection 2017 Feb 2.

20.

Micro-RNAs as promising biomarkers in cardiac diseases.

Akodad M, Mericskay M, Roubille F.

Ann Transl Med. 2016 Dec;4(24):551. doi: 10.21037/atm.2016.12.38. No abstract available.

Supplemental Content

Support Center